Immunotherapy for head and neck cancer

Keyphrases

• Head-and-neck Cancer 100%
• Long-term Survival 50%
• Specific Immunotherapy 50%
• Molecular Genetics 25%
• Tumor 25%
• Cancer Patients 25%
• Therapeutic Vaccine 25%
• Adjuvant Therapy 25%
• Patient Demographics 25%
• Cell-to-cell 25%
• Functional Outcome 25%
• Therapeutic Approaches 25%
• Complex Interactions 25%
• Dendritic Cells 25%
• Viral Vectors 25%
• Local-regional 25%
• Immunology 25%
• Early Phase Clinical Trials 25%
• Novel Therapies 25%
• Microscopic Disease 25%
• Treatment Advances 25%
• Micrometastatic Disease 25%
• Bacterial Vectors 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Immunotherapy 100%
• Head and Neck Cancer 100%
• Neoplasm 40%
• Disease 40%
• Long Term Survival 40%
• Malignant Neoplasm 20%
• Clinical Trial 20%
• Viral Vector 20%
• Bacterial DNA 20%
• Bacterial Vector 20%

Medicine and Dentistry

• Bacterial Vector 20%